Juan Fransiscus Wira

Mr. Juan Fransiscus Wira

Faculty of Medicine and Health Sciences, University of Jambi, Jambi City, Indonesia
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2025 in Nutrition and Health
Verified
Journal Article
Closed access
MIMuhammad Iqhrammullah
Muhammad Iqhrammullah
Juan Fransiscus WiraJuan Fransiscus Wira
Juan Fransiscus Wira
SNSamuel Partogi Nababan
Samuel Partogi Nababan
EOEunice Rima Christy Oey
Eunice Rima Christy Oey
SASeba Talat Al-Gunaid
Seba Talat Al-Gunaid
RMRadi Muharris Mulyana
Radi Muharris Mulyana
Background: Low serum 25-hydroxyvitamin D (25[OH]D) levels affect bone remodeling, contributing to the development and progression of knee osteoarthritis (OA). Aim: This meta-analysis aimed to estimate the prevalence of vitamin D deficiency in patients with knee OA. Methods: A systematic search was conducted in Europe PMC, Google Scholar, Scopus, Scilit, and Web of Science for studies published until 8 August 2024 that reported the prevalence and contributing factors of hypovitaminosis D in knee OA patients. Study quality was assessed using the Newcastle–Ottawa Scale. A random-effect meta-analysis with Freeman–Tukey double arcsine transformation estimated the pooled prevalence of vitamin D deficiency. Results: Out of 1695 records identified, 26 studies ( n = 4248 patients) met the inclusion criteria. The pooled prevalence of vitamin D deficiency was 56.72% (95% CI: 46.93–66.25). No significant difference was observed across publication periods of 2015–2019 ( p = 0.465) and 2020–2024 ( p = 0.407). Patients with an average body mass index (BMI) ≥28 kg/m² had a higher prevalence (65.62%, 95% CI: 49.23–80.32) compared to those with BMI <28 kg/m² (37.63%, 95% CI: 24.72–51.48). The prevalence was significantly higher in European countries (65.92%, 95% CI: 47.17–82.43) than in the USA ( p = 0.046). In Asia, the Middle East, and North Africa, prevalences were 60.96% (95% CI: 42.32–78.08) and 63.11% (95% CI: 43.8–80.47), respectively. Conclusion: Over half of knee OA patients had vitamin D deficiency, with higher prevalence in Europe and among individuals with obesity. Targeted screening for 25(OH)D levels in knee OA patients is recommended.

21 April 2025 in Kidney and Dialysis
Verified
Journal Article
Open access
PDF file
Muhammad Haneef GhifariMuhammad Haneef Ghifari
Muhammad Haneef Ghifari
SASeba Talat Al-Gunaid
Seba Talat Al-Gunaid
DRDerren David Rampengan
Derren David Rampengan
Juan Fransiscus WiraJuan Fransiscus Wira
Juan Fransiscus Wira
MSMaimun Syukri
Maimun Syukri
Muhammad IqhrammullahMuhammad Iqhrammullah
Muhammad Iqhrammullah
Protein-energy wasting (PEW) increases the morbidity and mortality in maintenance hemodialysis (MHD) patients. The existing screening tools (e.g., Malnutrition-Inflammation Score (MIS)) are time-consuming and require expertise. Consequently, assessing a more practical and reliable tool such as handgrip strength (HGS) is important, as it strongly correlates with the PEW status in patients undergoing MHD, in whom increased protein and fat breakdown leads to muscle strength and function loss. A systematic search of five databases identified studies assessing HGS’s predictive value for PEW in patients undergoing MHD, using MIS as the reference. The quality of the studies was evaluated with the updated QUADAS tool. A diagnostic meta-analysis was carried out to estimate the pooled sensitivity, specificity, sROC, and sAUC using a two-level mixed-effects model. From 350 records, five studies were obtained which were included for analysis. The pooled sensitivity and specificity of the HGS among male patients were 68% (95%CI: 63–73%) and 66% (95%CI: 53–77%), respectively. Among female patients, the pooled sensitivity and specificity were 73% (95%CI: 62–82%) and 65% (95%CI: 48–79%), respectively. The positive likelihood ratio and negative likelihood ratio for male patients were 2.0 (95%CI: 1.4 to 2.9) and 0.48 (95%CI: 0.38 to 0.60), respectively. Meanwhile, among female patients, the positive likelihood ratio and negative likelihood ratio were 2.1 (95%CI: 1.4–3.1) and 0.41 (95%CI: 0.29–0.59), respectively. The sAUC for males and females was estimated to be 0.69 (95%CI: 0.65 to 0.73) and 0.75 (95%CI: 0.71–0.79). In summary, the sensitivity and specificity of the HGS were modest for all sexes, with females being more sensitive. HGS may be useful for triaging during daily screening and guiding further examination, but it requires supporting measurements to be employed as a diagnostic tool. PROSPERO: CRD42024595677 as of 1 October 2024.

25 June 2026 in Journal of Asian Medical Students' Association
Verified
Journal Article
Open access
SNSamuel Nababan
Samuel Nababan
GUGresita Novelia Uirianto
Gresita Novelia Uirianto
Juan Fransiscus WiraJuan Fransiscus Wira
Juan Fransiscus Wira
WTWhitney Joycelyn Tenaya
Whitney Joycelyn Tenaya
DADeva Fitra Firdausa Anwar
Deva Fitra Firdausa Anwar
Introduction: Serum vitamin D concentration has been associated with PPD in previous studies. However, whether there is a dose-response relationship and if its supplementation during pregnancy can improve symptoms after delivery remains unclear. Objective: To evaluate the evidence on the association of vitamin D concentration during pregnancy towards PPD and whether its supplementation can improve symptoms Methods: Five databases were searched on September 27, 2025. Cohort studies were included for dose-response meta-analysis (DRMA), while randomized controlled trials (RCTs) were included for meta-analysis (MA) of supplementation. The outcome for MA of supplementation was postpartum Edinburgh Postnatal Depression Scale (EPDS) score using the effect measure of mean difference (MD), while the outcome for DRMA was the odds ratio (OR) of PPD after delivery. Certainty was assessed using GRADE for MA of supplementation. Results: Two prospective cohort studies were included for DRMA and two RCTs were included for MA of supplementation. There was a significant log linear dose-response relationship between vitamin D serum concentration and developing PPD with β = -0.0256 (95% CI = -0.0454 to -0.0057). Every 10 nmol/L increase was associated with OR = 0.77 (95% CI = 0.63 to 0.94). Meta-analysis of supplementation found a significant reduction in EPDS scores at 4 weeks after delivery (MD = -2.70; 95% CI = -3.68 to -1.71; low certainty). Conclusion: Vitamin D serum concentration during pregnancy is log-linearly associated with developing PPD after delivery and its supplementation during pregnancy may improve PPD symptoms. Further larger and high quality studies with more diverse pregnant populations are needed to improve certainty and generalizability of evidence. Keywords: Maternal health, Postpartum depression, Vitamin D

31 July 2026 in Discover Applied Sciences
Verified
Journal Article
Open access
PDF file
Muhammad IqhrammullahMuhammad Iqhrammullah
Muhammad Iqhrammullah
ADAida Dama
Aida Dama
EGEra Gorica
Era Gorica
Juan Fransiscus WiraJuan Fransiscus Wira
Juan Fransiscus Wira
DRDerren David Rampengan
Derren David Rampengan
Fahrul NurkolisFahrul Nurkolis
Fahrul Nurkolis
Marine ecosystems harbor evolutionarily distinct immune molecules that offer unprecedented opportunities for tackling non-communicable diseases (NCDs). Chief among these are shark-derived Variable New Antigen Receptors (VNARs) and lamprey-derived Variable Lymphocyte Receptors (VLRBs), adaptive immune architectures that evolved independently from immunoglobulin-based antibodies. Their compact size, exceptional stability, and unconventional binding surfaces enable access to cryptic or highly conserved epitopes, while their evolutionary divergence from mammalian systems minimizes cross-reactivity and enhances re-administration potential. These properties make VNARs and VLRBs true biomedical platforms, which are engineerable for precision diagnostics, mechanistic research, and targeted therapies. In diagnostics, they serve as the basis for robust biosensors, imaging probes, and flow cytometry reagents capable of operating in harsh or high-temperature environments. As research tools, they provide unique probes for tracking intracellular enzymes, mapping post-translational modifications, and studying receptor dynamics in NCD pathophysiology. Therapeutically, they possess the capacity to penetrate dense tissues and cross physiological barriers such as the blood–brain barrier, enabling novel strategies against cancer, autoimmune diseases, and neurodegeneration, including bispecific constructs, immune checkpoint modulators, and drug delivery vehicles. Marine-derived antibodies demonstrate how evolutionary diversity can inform the development of innovative biomedical platforms. Their integration into the prevention, diagnosis, and treatment landscape for NCDs will depend on rigorous preclinical and clinical evaluation, robust and scalable production processes, and thorough safety profiling across diverse clinical settings.

1 January 2026 in Trends in Psychiatry and Psychotherapy
Verified
Journal Article
Closed access
SNSamuel Partogi Nababan
Samuel Partogi Nababan
GUGresita Novelia Uirianto
Gresita Novelia Uirianto
Juan Fransiscus WiraJuan Fransiscus Wira
Juan Fransiscus Wira
WTWhitney Joycelyn Tenaya
Whitney Joycelyn Tenaya
DADeva Fitra Firdausa Anwar
Deva Fitra Firdausa Anwar